| Group Cancer Research |
Mo
| 02.11.2026 | 09:00 | 10:30 | virtuell (V0000.DB.000) | Abhaltung | fix | Online Pre-Lecture |
| |
Do
| 12.11.2026 | 14:00 | 18:00 | SR 57 - Groß (MC2.P.01.019) | Abhaltung | fix | |
| |
| Group Metabolism & Circulation |
Mo
| 02.11.2026 | 09:00 | 10:30 | virtuell (V0000.DB.000) | Abhaltung | fix | Online Pre-Lecture |
| |
Do
| 12.11.2026 | 14:00 | 18:00 | SR 64 - Mittel frontal (MC2.Q.01.029) | Abhaltung | fix | |
| |
| Group Microbiome & Infection |
Mo
| 02.11.2026 | 09:00 | 10:30 | virtuell (V0000.DB.000) | Abhaltung | fix | Online Pre-Lecture |
| |
Do
| 12.11.2026 | 14:00 | 18:00 | SR 65 - Mittel frontal (MC2.Q.01.027) | Abhaltung | fix | |
| |
| Group Neuroscience |
Mo
| 02.11.2026 | 09:00 | 10:30 | virtuell (V0000.DB.000) | Abhaltung | fix | Online Pre-Lecture |
| |
Do
| 12.11.2026 | 14:00 | 18:00 | SR 66 - Mittel frontal (MC2.Q.01.028) | Abhaltung | fix | |
| |
| Group Sustainable Health Research |
Mo
| 02.11.2026 | 09:00 | 10:30 | virtuell (V0000.DB.000) | Abhaltung | fix | Online Pre-Lecture |
| |
Do
| 12.11.2026 | 14:00 | 18:00 | SR 62 - Mittel frontal (MC2.Q.01.019) | Abhaltung | fix | |
| |